A specialist in clinical hypertension critiques ALLHAT

American Journal of Hypertension

Volumn 16, Issue 5 I, 2003, Pages 416-420

  Meltzer, Jay I ^a  

^a Columbia Univ Coll of Phys/Surgs ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CHLORTALIDONE; DIURETIC AGENT; LISINOPRIL;

ADULT; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CANCER; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DISEASE PREDISPOSITION; FATALITY; GASTROINTESTINAL HEMORRHAGE; GOUT; HEART INFARCTION; HEART VENTRICLE EXTRASYSTOLE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERURICEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; MEDICAL SPECIALIST; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SEXUAL DYSFUNCTION; SIDE EFFECT; TREATMENT OUTCOME;

EID: 0038741955     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(03)00570-3     Document Type: Editorial

References (10)

1. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic. the anti-hypertensive and lipid-lowering treatment to prevent heart attack (ALLHAT) JAMA 2002;288:2981-2997.
2. Appel LJ: The verdict from ALLHAT - Thiazide diuretics are the preferred initial therapy for hypertension (Editorial). JAMA 2002;288:3039.
3. Davis BR, Cutler JA, Gordon DJ, Furberg CD, Wright JT, Cushman WC, Grimm RG, LaRosa J, Whelton PK, Perry HM, Alderman MH, Ford CE, Oparil S, Francis C, Proschan M, Pressel S, Black HR, Hawkins CM, for the ALLHAT Research Group: Rationale and design for the Anti-hypertensive and Lipid-Lowering Treatment to Prevent Heart Attack trial (ALLHAT). Am J Hypertens 1995;9:342-351.
4. WHO-ISH Blood Pressure Lowering Treatment Trialists' Collaboration: Protocol for prospective collaborative overviews of major randomized trials of blood pressure lowering treatments. J Hypertens 1998;16:127-137.
5. McMahon S, Peto R, Cutler J, Collins R, Sorie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J: Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective, observations; studies corrected for the regression dilution bias. Lancet 1990;335:765-774.
6. Pocock SJ: Statistics in trial reports: "How to Spot Those Damn Lies." Symposium - The use and abuse of clinical trials: Annual Meeting American Society of Hypertension, May 2002, New York City, NY.
7. Franse LV, Pahor M, DiBari M, Somes G, Cushman WC: Hypokalemia associated with diuretic use and cardiovascular events in the SHEP. Hypertension 2000;35:1025-1030.
8. Hansson L, Lindholm LH, Ekbom T, Dahlof B, Lanke J, Schersten P-OW, Hedner T, DeFaire U, for the STOP-Hypertension-2 study group: Randomized trial of old and new anti-hypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet 1999;354:1751-1756.
9. Laragh JH: Laragh's Lessons in Renin System Pathophysiology for Treating Hypertension and Its Fatal Cardiovascular Consequences. Elsevier, New York, 2002, pp 1-174.
10. Materson BJ, Reda DJ, Cushman WC, et al: Single drug therapy for hypertension in men. A comparison of six agents with placebo. N Engl J Med 1993;328:914-921.